An amendment to this paper has been published and can be accessed via a link at the top of the paper
MicroRNAs (miRNAs) are a class of small noncoding RNA which exert post-transcriptional gene regulati...
Pulmonary arterial hypertension (PAH) results from endothelial cell (EC) damage leading to pulmonary...
In this review, the potential future role of microRNA-based therapies and their specific application...
An amendment to this paper has been published and can be accessed via a link at the top of the paper
Pulmonary arterial hypertension (PAH) is a severe disorder of lung vasculature that causes right hea...
Background. Pulmonary arterial hypertension (PAH) is a severe disorder leading to right heart failur...
Pulmonary arterial hypertension (PAH) is a severe disorder of lung vasculature that causes right hea...
Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-020-14966-x, published online 4 M...
AbstractPulmonary hypertension is a devastating and refractory disease and there is no cure for this...
Pulmonary hypertension (PH) is a fatal and untreatable disease, ultimately leading to right heart fa...
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertensio...
Introduction. Idiopathic pulmonary arterial hypertension (IPAH) is a severe cardiopulmonary disease ...
MicroRNAs (miRNAs) have emerged as a new class of posttranscriptional regulators of many cardiac and...
Pulmonary Arterial hypertension (PAH) is a devastating progressive disease that significantly decrea...
Copyright © 2015 Irene Sarrion et al. This is an open access article distributed under the Creative ...
MicroRNAs (miRNAs) are a class of small noncoding RNA which exert post-transcriptional gene regulati...
Pulmonary arterial hypertension (PAH) results from endothelial cell (EC) damage leading to pulmonary...
In this review, the potential future role of microRNA-based therapies and their specific application...
An amendment to this paper has been published and can be accessed via a link at the top of the paper
Pulmonary arterial hypertension (PAH) is a severe disorder of lung vasculature that causes right hea...
Background. Pulmonary arterial hypertension (PAH) is a severe disorder leading to right heart failur...
Pulmonary arterial hypertension (PAH) is a severe disorder of lung vasculature that causes right hea...
Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-020-14966-x, published online 4 M...
AbstractPulmonary hypertension is a devastating and refractory disease and there is no cure for this...
Pulmonary hypertension (PH) is a fatal and untreatable disease, ultimately leading to right heart fa...
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertensio...
Introduction. Idiopathic pulmonary arterial hypertension (IPAH) is a severe cardiopulmonary disease ...
MicroRNAs (miRNAs) have emerged as a new class of posttranscriptional regulators of many cardiac and...
Pulmonary Arterial hypertension (PAH) is a devastating progressive disease that significantly decrea...
Copyright © 2015 Irene Sarrion et al. This is an open access article distributed under the Creative ...
MicroRNAs (miRNAs) are a class of small noncoding RNA which exert post-transcriptional gene regulati...
Pulmonary arterial hypertension (PAH) results from endothelial cell (EC) damage leading to pulmonary...
In this review, the potential future role of microRNA-based therapies and their specific application...